Drug intelligence / Profile preview

thymogen

Development stage
Unknown
Lead developer
Saint Petersburg Institute of Bioregulation and Gerontology
Modality
Peptides
Administration
Intranasal, Intramuscular, Topical
01

Overview

Thymogen is a synthetic dipeptide consisting of L-glutamyl-L-tryptophan, developed by the St. Petersburg Institute of Bioregulation and Gerontology. It acts as an immunomodulator that normalizes cellular immunity by regulating the count and functional activity of T-lymphocytes. Thymogen is primarily indicated for the treatment and prevention of secondary immunodeficiencies associated with chronic infectious and inflammatory diseases, trauma, surgery, and the side effects of chemotherapy or radiotherapy. It is available in several formulations, including an intranasal spray, an injectable solution, and a topical cream, and has been used in Russia and CIS countries for various conditions including respiratory infections and dermatological disorders like atopic dermatitis.

Brand names
ThymogenТимоген
Other names
L-glutamyl-L-tryptophanGlu-Trp
02

Targets

MC2R (Adrenocorticotropic Hormone Receptor)Sequence-specific double-stranded DNA motifs (dsDNA motifs)

Beyond the preview

Go deeper on thymogen.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on thymogen.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call